Zurueck zur Suche

Reporte zur Charge U003873

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NV 2 NC 1 SC 1 CO 1

VAERS 1749668

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

mild
Staat
NC
Alter
1,0
Geschlecht
F
Eingang
30.09.2021
Impfdatum
17.09.2021
Beginn
27.09.2021
Tage bis Beginn
10,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Rash

Symptomtext

Rash started 9 days after vaccines were given. No treatment other than Tylenol, ibuprofen and Benadryl if needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1423795

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

mild
Staat
SC
Alter
0,3
Geschlecht
F
Eingang
24.06.2021
Impfdatum
21.06.2020
Beginn
22.06.2021
Tage bis Beginn
366,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Injection site erythema Injection site induration Injection site nodule Injection site papule Rash papular

Symptomtext

Approximately 30 hours after vaccines administered, she developed a hard, erythematous "knot" in her right thigh where the Prevnar was admnistered. From there, erythematous papules spread from that area. However 3 days after the vaccine, the papular rash to spread to the other leg (also concentrated around vaccine site), chest, arms, legs, palms and face. No mucosal lesions. Not itchy or painful. Some diarrhea (possibly from Amoxicilin), but acting normally, no fever, eating and drinking well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
1 week ago diagnosed with presumptive AOM in the Emergency Department due to high fever and started on amoxicillin
Vorgeschichte
N/A
Andere Medikamente
Amoxicillin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2623408

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
CO
Alter
-
Geschlecht
M
Eingang
28.04.2023
Impfdatum
26.04.2023
Beginn
26.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No further information provided, no additional AEs, no PQCs.; one dose of PEDVAXHIB from expired lot on 15APR2023 was administered on 26APR2023.; This spontaneous report was received from a certified medical assistant and refers to a 15-month-old male patient. No information regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies was provided. On 26-APR-2023, the patient was vaccinated with expired dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) 0.5 milliliter, once, lot # U003873 was confirmed to be valid, expiration date 15-APR-2023 for prophylaxis (route and site of administration were not reported). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2098066

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
NV
Alter
0,2
Geschlecht
F
Eingang
09.02.2022
Impfdatum
27.12.2021
Beginn
27.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Ill-defined disorder Inappropriate schedule of product administration Product storage error

Symptomtext

adverse experience; revaccinated; Temperature excursion involving, PEDVAX HIB; This spontaneous report has been received from a medical assistant (also reported as a nurse), concerning 2-month-old of female patient. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 27-DEC-2021, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot # U003873, expiration date: 15-APR-2023, which have been verified to be valid lot number for haemophilus b conjugate vaccine (meningococcal protein conjugate) in left thigh (strength, exact dose, dose # and route of administration were not provided) for prophylaxis. The vaccine was exposed to a temperature excursion of below 36?F (30.4?F) for 0 hours 35 minutes on 08-DEC-2021. Digital data logger was involved. On an unknown date, the patient experienced unspecified adverse reaction (ill-defined disorder). The patient's parents agreed to revaccination (inappropriate schedule of vaccine administered). The outcome of the event of ill-defined disorder was reported as resolved on an unknown date. The causality assessment between the event of ill-defined disorder and suspect vaccine was considered as unknown. The reporter considered the event of ill-defined disorder to be important medical event (medically significant). This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-2201USA000582:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ill-defined disorder
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2098064

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
NV
Alter
0,3
Geschlecht
F
Eingang
09.02.2022
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Ill-defined disorder Inappropriate schedule of product administration Product storage error

Symptomtext

adverse experience; revaccinated; Temperature excursion involving, PEDVAX HIB, RECOMBIVAX HB, VAQTA, GARDASIL 9, and ROTATEQ; This spontaneous report has been received from a medical assistant (also reported as a nurse), concerning 4-month-old of female patient. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 20-DEC-2021, the patient was vaccinated with an improperly stored doses haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot # U003873, expiration date: 15-APR-2023, which have been verified to be valid lot numbers for haemophilus b conjugate vaccine (meningococcal protein conjugate) administered in left thigh and with rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally (lot # 1821803, expiration date: 26-JUL-2022 (also reported as 25-JUL-2022), which have been verified to be valid lot numbers for rotavirus vaccine, live, oral, pentavalent (strengths, doses # and exact doses were not provided) for prophylaxis. The vaccines were exposed to a temperature excursion of below 36?F (30.4?F) for 0 hours 35 minutes on 08-DEC-2021. Digital data logger was involved. On an unknown date, the patient experienced unspecified adverse reaction (ill-defined disorder). The patient's parents agreed to revaccination (inappropriate schedule of vaccine administered). The outcome of the event of ill-defined disorder was reported as resolved on an unknown date. The causality assessment between the event of ill-defined disorder and suspect vaccine was considered as unknown. The reporter considered the event of ill-defined disorder to be important medical event (medically significant). This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-2201USA000582:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ill-defined disorder
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1941652

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2111USA004277: US-009507513-2112USA003881: US-009507513-2112USA003882: US-009507513-2112USA003883: US-009507513-2112USA003884:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1941651

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2111USA004277: US-009507513-2112USA003881: US-009507513-2112USA003882: US-009507513-2112USA003883: US-009507513-2112USA003885:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1941650

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2111USA004277: US-009507513-2112USA003881: US-009507513-2112USA003882: US-009507513-2112USA003884: US-009507513-2112USA003885:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1941649

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2111USA004277: US-009507513-2112USA003883: US-009507513-2112USA003884: US-009507513-2112USA003885: US-009507513-2112USA003881:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1941648

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2112USA003883: US-009507513-2112USA003884: US-009507513-2112USA003885: US-009507513-2111USA004277: US-009507513-2112USA003882:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1941605

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U003873

gering
Staat
-
Alter
-
Geschlecht
U
Eingang
11.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No signs or symptoms reported; PEDVAX HIB was administered to patients after the excursion occurred; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided. On 26-OCT-2021, haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced temperature excursion with 35.0 Fahrenheit degrees (F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There was no previous temperature excursion. On an unknown date in 2021, after the excursion occurred, the patient was vaccinated with the improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (1 time dose, lot # U003873, expiration date 15-APR-2023; strength, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No signs or symptoms reported. No other adverse event (AE) or product quality complaint (PQC) was reported. This is one of several reports received from the same reporter.; Sender's Comments: 2112USA003883: 2112USA003885: 2112USA003882: 2112USA003881: 2112USA003884:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-